BCR-ABL was shown to regulate the cell cycle in CML cells at least in part by inducing proteasome-mediated degradation of the cell cycle inhibitor p27(Kip1), which depends on SKP2 [295]. This evidence concerns the gene CDKN1B and chronic myelogenous leukemia, BCR-ABL1 positive.